Paracodin (Dihydrocodeine Tartrate)

Dihydrocodeine tartrate, the active ingredient in Paracodin, is an opioid analgesic presented as a strength/form for oral use. It is used to treat moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Paracodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paracodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracodin is an opioid analgesic that acts on the central nervous system to relieve pain.

- Moderate to severe acute pain: Provides effective relief when non‑opioid analgesics are inadequate. - Post‑operative pain: Helps manage pain following surgical procedures. - Cancer‑related pain: Used as part of a multimodal regimen for cancer patients experiencing moderate pain. - Chronic non‑cancer pain: May be prescribed for long‑term pain management under specialist supervision.

Paracodin may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Dizziness - Dry mouth - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Allergic reactions such as rash, itching, or anaphylaxis - Hallucinations or delirium - Seizures - Dependence, tolerance, and withdrawal symptoms upon abrupt discontinuation

When using Paracodin, several safety considerations should be observed.

- Assess pain severity: Ensure the drug is appropriate for the level of pain. - Monitor for respiratory depression: Watch for slowed breathing, especially in opioid‑naïve patients. - Evaluate liver and kidney function: Adjust use if significant impairment is present. - Avoid concurrent CNS depressants: Limit use with alcohol, benzodiazepines, or other sedatives. - Pregnancy and lactation: Use only if clearly needed, after risk‑benefit assessment. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Paracodin can interact with several other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Other opioids or strong CNS depressants: May cause profound respiratory depression. - MAO inhibitors: Can precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): May increase dihydrocodeine levels. - Anticholinergic agents: Can worsen constipation. - Diuretics: May enhance hypotensive effects. - Alcohol: Increases sedation and respiratory risk. - Sedating antihistamines: May add to drowsiness.